Skip to main content
. 2021 Jan 26;11(2):173. doi: 10.3390/diagnostics11020173

Figure 1.

Figure 1

Receiver operating characteristic curves from the model with IOTA SR alone, CA-125 alone, and combined IOTA SR and CA-125 models (IOTA SR X CA-125) for premenopausal and postmenopausal women. IOTA SR, International Ovarian Tumor Analysis Simple Rules. Evaluation of diagnostic added-value of CA-125 in (a) premenopausal women and (b) postmenopausal women.